Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
15 February 1993 | Volume 118 Issue 4 | Pages 279-281
Endogenous adenosine, which accumulates during hypoxia and ischemia, may perpetuate asystole. Therefore, patients with cardiac arrest were prospectively studied to see if their immediate outcome could be improved with aminophylline, a competitive antagonist of adenosine. Fifteen consecutive patients with cardiac arrest due to asystole or to nonperfusing bradyarrhythmias, who failed to respond to intravenous atropine and epinephrine, were treated with aminophylline (rapid intravenous injection of 250 mg). Establishment of a stable heart rhythm with sufficient blood pressure to allow discontinuation of closed-chest cardiac massage was achieved in 11 of 15 (73%) patients. All these 11 patients were alive 60 minutes after resuscitation. One patient survived, without neurologic damage. We conclude that the immediate outcome of patients with asystole refractory to standard treatment may be improved with aminophylline. Further study is warranted to determine if earlier administration of aminophylline during cardiac arrest will improve long-term outcome.
Hypoxia and ischemia lead to the interstitial accumulation of endogenous adenosine [3], a metabolite with pronounced depressant effects on atrioventricular nodal conduction as well as on automaticity of cardiac pacemakers (sinus node, atrioventricular junction, His bundle, and Purkinje fibers) [3-5]. Aminophylline, a competitive antagonist of adenosine [6], has been used to treat atrioventricular conduction disturbances related to inferior myocardial infarction, with conflicting results [7, 8]. These and other studies on the effects of aminophylline on bradyarrhythmias [3] have been of relatively stable patients. We evaluated the effects of aminophylline during bradyasystolic arrest refractory to conventional therapy.
Beginning in 1992, the cardiologist in the resuscitation team administered aminophylline to all patients who fulfilled all of the following criteria: 1) apnea without central pulse; 2) asystole or severe bradyarrhythmia [heart rate < 30 beats/min] documented as a primary arrhythmia or after defibrillation; 3) failure to respond to closed-chest cardiac massage and mechanical ventilation with 100% oxygen; 4) failure to respond to atropine (
Immediate Response to Aminophylline
In 11 of the 15 patients with cardiac arrest refractory to epinephrine and atropine, a stable heart rhythm (rate BRIEF REPORT
Aminophylline for Bradyasystolic Cardiac Arrest Refractory to Atropine and Epinephrine
Only 0% to 3% of patients with cardiac arrest and asystole or hypoperfusive bradyarrhythmias survive [1]. This holds true if asystole is the first rhythm recorded or if it occurs after defibrillation [1]. Standard therapy for asystole includes intravenous epinephrine and atropine along with mechanical ventilation and closed-chest cardiac massage [2].
Methods
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
The Tel Aviv Medical Center is a 650-bed university hospital. If cardiac arrest occurs, a resuscitation team including a cardiologist can be summoned. Basic and advance life support are started immediately by medical personnel in the ward, including defibrillation and administration of a "first round" of drugs. Thus, if the resuscitation team is summoned, it is usually for patients who failed to respond to these initial resuscitation procedures.
2 mg) and epinephrine [
2 mg] given intravenously and followed by saline flushing; 5) consent from the physician in charge of the patient at the ward. Patients with cardiac arrest secondary to trauma or terminal cardiogenic shock were not included. Aminophylline (Teva Pharmaceuticals, Jerusalem, Israel), 250 mg, was administered as a rapid bolus through the same vein where the previous drugs had been given. The study was approved by the Ethical Committee of the hospital.
Results
![]()
Top
Methods
Results
Discussion
Author & Article Info
References
Fifteen consecutive patients (11 men and 4 women, aged 71 ± 11 years) with cardiac arrest not responding to atropine and epinephrine were treated with aminophylline. Cardiac arrest occurred after myocardial infarction or deterioration of heart failure or sepsis in five, eight, and one patient, respectively. One patient had in-hospital sudden death after surgery. Cardiac arrest was not witnessed in nine patients. Asystole was the first rhythm recorded during cardiac arrest in 11 patients, whereas asystole or a pulseless bradyarrhythmia occurred after defibrillation in the last 4 patients. Before aminophylline administration, all patients received 2 to 7 mg (3.8 ± 2.2 mg) epinephrine and atropine (2 mg), and one patient also received isoproterenol.
75 beats/min with measurable blood pressure) appeared within 30 seconds of the aminophylline injection (Figure 1). In all but 4 of these 11 patients, a supraventricular rhythm occurred after aminophylline injection. In the last four a regular wide QRS tachycardia, probably of ventricular origin (110 to 160 beats/min), was initially recorded; the tachycardia eventually converted to sinus rhythm without additional intervention. Sinus rhythm without palpable pulses was obtained in one additional patient. Thus, cardiac electrical activity was restored in 12 of 15 patients after aminophylline injection. The other three patients, who showed no restoration of spontaneous electrical activity, had cardiac arrest that was not witnessed: These patients failed to respond to atropine, high-dose epinephrine, and aminophylline; they also failed to respond to isoproterenol and cardiac pacing.
|
Short-Term Outcome
All the 11 patients who had a good immediate response to aminophylline were alive 60 minutes after resuscitation; however, 10 of these patients eventually died 4 hours to 15 days after resuscitation. Death was caused by cardiogenic shock after resuscitation (eight patients) or anoxic brain damage (two patients) without further attempts at resuscitation. Only one of these patients had a malignant ventricular tachyarrhythmia after aminophylline administration. This patient originally had ventricular fibrillation with eventual drug-refractory asystole. A spontaneous heart rhythm appeared after aminophylline injection, but ventricular fibrillation recurred 15 minutes later. Again, asystole occurred after defibrillation, and only sporadic QRS complexes appeared after repeated epinephrine and atropine administration. Isoproterenol failed to accelerate this ventricular rhythm. In contrast, aminophylline promptly restored spontaneous, stable heart rhythm once again. Finally, one patient was discharged alive and without brain damage.
Discussion
|
|---|
|
|
|---|
-adrenergic stimulators [9]. Extreme bradycardia and transient asystole are dose-dependent effects of intravenously administered adenosine [3]. Thus, release of endogenous adenosine to the myocardial interstitium occurring during hypoxemia or anoxia [3] could cause or perpetuate such bradyarrhythmias. The salutary effects of aminophylline might have been mediated by its competitive antagonism with accumulated endogenous adenosine. In addition, aminophylline may have acted synergistically with previously administered epinephrine by inhibiting phosphodiesterase activity or by further releasing endogenous catecholamines [10]. Finally, adenosine attenuates the positive chronotropic effects of ß-adrenergic stimulation on ventricular pacemakers at the level of the His-Purkinje system, and this antiadrenergic effect of adenosine may be abolished with aminophylline [5].
Our doses of epinephrine are in agreement with current recommendations [2]. Restoration of sinus rhythm could have been coincidental and unrelated to aminophylline administration. However, appearance of a stable heart rhythm within seconds of aminophylline administration, regardless of the time previously spent with resuscitation maneuvers, is a result that makes this possibility unlikely. Endogenous adenosine may prevent reperfusion injury to the heart and brain [11]; thus, the eventual death of our patients could have been due to adenosine antagonism induced with aminophylline. A more plausible explanation for this poor outcome relates to several characteristics of our patients, which are known predictors of an adverse prognosis, namely, severe underlying disease, asystole, and cardiac arrest that is not witnessed [1]. Patients eventually responding to cardiac support maneuvers or to atropine or epinephrine were not included in our study; therefore, only patients at high risk for immediate death were actually treated with aminophylline. Thus, rather than discouraging the use of aminophylline, the dramatic response to aminophylline after prolonged unsuccessful efforts with other drugs indicates that aminophylline might be used earlier in resuscitation maneuvers.
Author and Article Information
|
|---|
|
|
|---|
References
|
|---|
|
|
|---|
1. Roberts D, Landolfo K, Light RB, Dobson K. Early predictors of mortality for hospitalized patients suffering cardiopulmonary arrest. Chest. 1990; 97:413-9.
2. Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care, III: adult advanced cardiac life support. JAMA 1992; 268:2199-2241.
3. Belardinelli L, Linden J, Berne RM. The cardiac effects of adenosine. Prog Cardiovasc Dis. 1989; 32:73-97.
4. Pelleg A, Hurt C, Miyagawa A, Michelson EL, Dreifus LS. Differential sensitivity of cardiac pacemakers to exogenous adenosine in vivo. Am J Physiol. 1990; 258:H1815-22.
5. Lerman BB, Wesley RC, DiMarco JP, Haines DE, Belardinelli L. Antiadrenergic effects of adenosine on His-Purkinje automaticity. Evidence for accentuated antagonism. J Clin Invest. 1988; 82:2127-35.
6. Belardinelli L, Fenton RA, West A, Linden J, Althaus JS, Berne RM. Extracellular action of adenosine and the antagonism by aminophylline on the atrioventricular conduction of isolated perfused guinea pig and rat hearts. Circ Res. 1982; 51:569-79.
7. Wesley RC, Lerman BB, DiMarco JP, Berne RM, Belardinelli L. Mechanism of atropine-resistant atrioventricular block during inferior myocardial infarction: possible role of adenosine. J Am Coll Cardiol. 1986; 8:1232-4.
8. Strasberg B, Bassevich R, Mager A, Kusniec J, Sagie A, Sclarovsky S. Effects of aminophylline on atrioventricular conduction in patients with late atrioventricular block during inferior wall acute myocardial infarction. Am J Cardiol. 1991; 67:527-8.
9. Paradis NA, Koscove EM. Epinephrine in cardiac arrest: a critical review. Ann Emerg Med. 1990; 19:1288-301.
10. Vestal RE, Eiriksson CE, Musser B, Ozaki LK, Halter JB. Effect of intravenous aminophylline on plasma levels of catecholamines and related cardiovascular and metabolic responses in man. Circulation. 1983; 67:162-71.
11. Hori M, Gotoh K, Kitakaze M, Iwai K, Iwakura K, Sato H, et al. Role of oxygen-derived free radicals in myocardial edema and ischemia in coronary microvascular embolization. Circulation. 1991; 84: 828-40.
This article has been cited by other articles:
![]() |
M. P. Anstadt and J. E. Lowe Cardiopulmonary Resuscitation Card. Surg. Adult, January 1, 2008; 3(2008): 487 - 506. [Full Text] |
||||
![]() |
Part 4: Advanced Life Support Circulation, November 29, 2005; 112(22_suppl): III-25 - III-54. [Full Text] [PDF] |
||||
![]() |
H. L. Collins and S. E. DiCarlo Acute exercise increases the ventricular arrhythmia threshold via the intrinsic adenosine receptor system in conscious hypertensive rats Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1020 - H1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Anstadt and J. E. Lowe Cardiopulmonary Resuscitation Card. Surg. Adult, January 1, 2003; 2(2003): 471 - 494. [Full Text] |
||||
![]() |
B. D. Bertolet, L. Belardinelli, E. A. Franco, W. W. Nichols, R. A. Kerensky, and J. A. Hill Selective Attenuation by N-0861 (N6-Endonorboran-2-yl-9-Methyladenine) of Cardiac A1 Adenosine Receptor–Mediated Effects in Humans Circulation, May 15, 1996; 93(10): 1871 - 1876. [Abstract] [Full Text] |
||||
![]() |
B. B. Lerman and E. D. Engelstein Metabolic Determinants of Defibrillation : Role of Adenosine Circulation, February 1, 1995; 91(3): 838 - 844. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||